With 2.13 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.19 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $18.18 whereas the lowest price it dropped to was $16.89. The 52-week range on KMTS shows that it touched its highest point at $26.15 and its lowest point at $14.15 during that stretch. It currently has a 1-year price target of $27.50.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of KMTS was up-trending over the past week, with a rise of 17.56%, but this was down by -22.70% over a month.
Float and Shares Shorts:
At present, 51.35 million KMTS shares are outstanding with a float of 16.92 million shares on hand for trading. On 2025-06-13, short shares totaled 1.14 million, which was 221.0 higher than short shares on 1747267200. In addition to Mr. Brian Webster as the firm’s Founder, President, CEO & Director, Ms. Traci S. Umberger serves as its Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director.
Institutional Ownership:
Through their ownership of 0.87343 of KMTS’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-01-31, KMTS reported revenue of $15090000.0 and operating income of -$20601000.0. The EBITDA in the recently reported quarter was -$18070000.0 and diluted EPS was -$0.501334.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With KMTS analysts setting a high price target of 30.0 and a low target of 23.0, the average target price over the next 12 months is 27.5. Based on these targets, KMTS could surge 69.78% to reach the target high and rise by 30.16% to reach the target low. Reaching the average price target will result in a growth of 55.63% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
